Trial Information
A Clinical Study of X-Ray Volume Imaging to Evaluate the Daily Set-Up Accuracy of Conformal Prostate Radiotherapy
Inclusion Criteria:
- Diagnosis of adenocarcinoma of the prostate
- Patient undergoing escalated dose conformal external beam radiotherapy.
- Patient has low or intermediate risk prognostic factors: all of PSA <21, Gleason
score <8, clinical T category
- Informed consent
Exclusion Criteria:
- No diagnosis of adenocarcinoma of the prostate
- Patient not undergoing escalated dose conformal radiotherapy
- Patient does not have low or intermediate risk prognostic factors
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
To evaluate he feasibility of daily X-ray volume imaging during conformal radiotherapy.
Principal Investigator
Charles Catton, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Princess Margaret Hospital, Canada
Authority:
Canada: Ethics Review Committee
Study ID:
UHN REB 03-0483-CE
NCT ID:
NCT00188799
Start Date:
November 2003
Completion Date:
November 2004
Related Keywords:
- Prostatic Neoplasms
- Neoplasms
- Prostatic Neoplasms